COMFORTIS (SPINOSAD) 140MG CHEWABLE TABLETS أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

comfortis (spinosad) 140mg chewable tablets

elanco australasia pty ltd - spinosad manufacturing concentrate - oral tablet - spinosad manufacturing concentrate ungrouped active 140.0 mg/tb - parasiticides - dog - with exclusions see label - canine summer eczema | cat flea | flea allergy dermatitis | summer eczema

Astromide نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

astromide

merck sharp & dohme (new zealand) limited - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin indigo carmine lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid titanium dioxide - astromide capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Estracyt نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

estracyt

pharmacia limited company trading as pharmacia - estramustine phosphate 140mg - capsule - 140 mg - active: estramustine phosphate 140mg

Carbosylane 140mg/45mg Capsules أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

carbosylane 140mg/45mg capsules

laboratoires grimberg - charcoal, activated; simeticone - capsule - 140 mg/45 milligram(s) - antiflatulents; silicones

TEMOZOLOMIDE ACTAVIS 140 Milligram Capsules Hard أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

temozolomide actavis 140 milligram capsules hard

actavis group ptc ehf - temozolomide - capsules hard - 140 milligram - other alkylating agents

Temozolomide FAIR-MED 140mg hard capsules مالطا - الإنجليزية - Medicines Authority

temozolomide fair-med 140mg hard capsules

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - temozolomide - hard capsule - temozolomide 140 mg - antineoplastic agents

Voltarol 140mg Medicated Plaster المملكة المتحدة - الإنجليزية - myHealthbox

voltarol 140mg medicated plaster

novartis consumer health uk limited - diclofenac sodium - medicated plaster - 140mg - topical products for joint and muskular pain; antiinflammatory preparations, non-steroids for topical use - local symptomatic and short term treatment of pain in acute strains, sprains or bruises of the extremities following blunt trauma, e.g. sports injuries in adolescents from 16 years of age and adults

PYLERA 140/125/12 Milligram Capsule أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

pylera 140/125/12 milligram capsule

allergan pharmaceuticals international limited - bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride - capsule - 140/125/12 milligram - combinations for eradication of helicobacter pylori

Parofor 140 mg/ml solution for use in drinking water, milk or milk replacer for pre-ruminant cattle and pigs أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

parofor 140 mg/ml solution for use in drinking water, milk or milk replacer for pre-ruminant cattle and pigs

huvepharma nv - paromomycin - oral solution - 140 milligram(s)/millilitre - paromomycin - cattle, pigs - antibiotics

Temozolomide Capsules 140 mg أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

temozolomide capsules 140 mg

idt australia ltd - temozolomide, quantity: 140 mg - capsule, hard - excipient ingredients: lactose; sodium starch glycollate type a; silicon dioxide; stearic acid; tartaric acid; gelatin; purified water; sodium lauryl sulfate; indigo carmine; titanium dioxide; shellac; isopropyl alcohol; propylene glycol; iron oxide black; sodium methyl hydroxybenzoate; sodium propyl hydroxybenzoate - temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.